Skip to main content
XILONG SCIENTIFIC CO.,LTD. logo

XILONG SCIENTIFIC CO.,LTD. — Investor Relations & Filings

Ticker · 002584 ISIN · CNE1000013M8 LEI · 300300BP2CTY4GS0RU69 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,924 across all filing types
Latest filing 2026-05-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002584

About XILONG SCIENTIFIC CO.,LTD.

https://www.xilongs.com

Xilong Scientific Co., Ltd. specializes in the research, development, production, and distribution of high-purity chemical reagents and fine chemicals. The company's product portfolio encompasses a wide range of laboratory reagents, electronic chemicals, and pharmaceutical raw materials. Key offerings include high-purity solvents, analytical reagents, and specialized chemicals for the semiconductor and printed circuit board industries. Additionally, the firm operates in the healthcare sector, providing in vitro diagnostic reagents and medical devices. Xilong Scientific serves diverse markets such as scientific research, industrial manufacturing, environmental monitoring, and clinical diagnostics. The company focuses on technical innovation and quality control to support advanced applications in electronics, biotechnology, and pharmaceutical synthesis.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺( 孟兆胜)
Board/Management Information Classification · 89% confidence The document is a formal declaration and commitment by an independent director candidate for Xilong Scientific’s sixth Board, outlining qualifications, independence criteria, and compliance with regulatory requirements. It is directly related to board composition and director appointments, not a financial report or voting outcome. Therefore it falls under Board/Management Information.
2026-05-22 Chinese
第六届董事会第十八次会议决议公告
Board/Management Information Classification · 96% confidence The document is a formal announcement of the resolutions from the company’s sixth board meeting, detailing the resignation of an independent director, the proposed appointment of a new independent director, adjustments to board committees, and the calling of a shareholders meeting. These are changes in the composition and governance of the board, which fall squarely under Board/Management Information.
2026-05-22 Chinese
独立董事提名人声明与承诺
Board/Management Information Classification · 91% confidence The document is a formal nomination statement and commitment for an independent director candidate by the company’s board. It details qualifications, legal compliance, and board-related commitments for the nominee. It does not contain financial data, voting results, or call transcripts. This is an announcement regarding board/management changes (appointment of an independent director).
2026-05-22 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is an official announcement of the voting results and resolutions from the 2026 first extraordinary shareholders’ meeting (EGM), detailing proposals, vote counts, approval rates, and legal opinions. This matches the Declaration of Voting Results & Voting Rights Announcements category.
2026-05-22 Chinese
北京中银律师事务所关于西陇科学股份有限公司2026年第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion letter from a law firm concerning the convening, procedural compliance, and actual vote counts of an Extraordinary General Meeting (2026 First EGM) of Xilong Science Co., Ltd. It provides detailed voting results for the resolutions and confirms the legality of the meeting process. This aligns with the “Declaration of Voting Results & Voting Rights Announcements” category, which covers official vote outcomes at shareholder meetings (AGM or EGM).
2026-05-22 Chinese
关于召开2026年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice calling the 2026 second extraordinary shareholders’ meeting (an EGM). It provides meeting date/time, agenda items, voting procedures (including proxy authorization forms), and instructions for shareholders to vote in person or by proxy. It is not the meeting results or minutes, nor a financial report. It constitutes materials sent to shareholders to inform them of the meeting and solicit their votes. Under the filing definitions, this best matches “Proxy Solicitation & Information Statement (PSI).”
2026-05-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.